JPRN-UMIN000045516招募中未知
Consideration of the validity of the medicine treatment of artificial knee joint replacement chronic postsurgical pain (searching study) - chronic postsurgical pain in TKA(medicine treatment)
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 105
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)the patient who is planning to carry out TKA in simultaneousness of left and right 2)patient with a spirit disease 3)patient with taboo and TRAMCET Combination Tablets and Cymbalta Capsules 4)additionally the patient who judged that a study person in charge was unsuitable as a subject of research person
研究者
相似试验
进行中（未招募）
1 期
Evaluation of the necessity of a pharmacological treatment with antipsychotics for the prevention of relapse in long-term stabilized schizophrenic patients: a randomized, single-blind, longitudinal trialschizophrenia or schizoaffective disorder in remission for at least 3 years under a stable antipsychotic medication.MedDRA version: 17.0Level: PTClassification code 10039626Term: SchizophreniaSystem Organ Class: 10037175 - Psychiatric disordersMedDRA version: 17.0Level: PTClassification code 10039621Term: Schizoaffective disorderSystem Organ Class: 10037175 - Psychiatric disordersEUCTR2013-000338-37-DETechnische Universität München, vertreten durch das Klinikum rechts der Isar25
尚未招募
3 期
Verifying the rubrics Food and Drinks in Synthesis RepertoryCTRI/2024/02/063332I
已完成
不适用
BEDAQUILINE AND DELAMANID FOR MDR-TB TREATMENT-A15 Respiratory tuberculosis, bacteriologically and histologically confirmedRespiratory tuberculosis, bacteriologically and histologically confirmedA15PER-016-16Institutos Nacionales de Salud (NIH, siglas en ingles) de los Estados Unidos de America,6
已完成
不适用
Evaluation of the safety, tolerability, pharmacokinetics and pharmacodynamics of topically applied NT-077 (tiotropium bromide) in healthy volunteers.hyperhydrosisprimary hyperhidrosis is a not well-delineated conditionexcessive sweat productionNL-OMON50872otoxins Holding B.V.4
已完成
不适用
Evaluating the safety, tolerability, and pharmacodynamic properties of IW-6463 in healthy elderly subjects.Alzheimer's diseaseDementiaNL-OMON48314Cyclerion Therapeutics, Inc.24